Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicholas Atwal"'
Publikováno v:
Neuropharmacology. 144:115-121
Clinical studies have shown that the major psychoactive ingredient of Cannabis sativa Δ9-tetrahydrocannabinol (THC) has some analgesic efficacy in neuropathic pain states. However, THC has a significant side effect profile. We examined whether the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d273f5200f245cad1357db24b233a26
https://doi.org/10.1016/j.neuropharm.2018.10.006
https://doi.org/10.1016/j.neuropharm.2018.10.006
Publikováno v:
Journal of neurochemistryReferences. 152(1)
It is thought that endogenous cannabinoids have a role in the analgesia induced by specific forms of stress. We examined if the role of endogenous cannabinoids is also dependent upon the mode of nociception, and whether this could be altered by drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8efae3096b1aead6b4cae25b3061c7b9
https://pubmed.ncbi.nlm.nih.gov/31571215
https://pubmed.ncbi.nlm.nih.gov/31571215
Publikováno v:
Pain. 158(12)
Cannabis and its psychoactive constituent Δ9-tetrahydrocannabinol (THC) have efficacy against neuropathic pain, however, this is hampered by their side effects. It has been suggested that co-administration with another major constituent cannabidiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1da56d0956a756be713b13abf4b9d0a
https://pubmed.ncbi.nlm.nih.gov/28885457
https://pubmed.ncbi.nlm.nih.gov/28885457
Publikováno v:
Journal of Neurochemistry; Jan2020, Vol. 152 Issue 1, p92-102, 11p
Publikováno v:
PAIN; Dec2017, Vol. 158 Issue 12, p2452-2460, 9p